Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Ventana seeks FDA premarket approval for ALK companion diagnostic for lung cancer

Jan. 22, 2015

First-in-human results show efficacy of a novel PET tau tracer

Jan. 22, 2015

New compounds assessed as potential PET tracers for AD and other tauopathies

Jan. 22, 2015

Researchers present data on the diagnostic utility of [11C]PBB-3-based PET imaging

Jan. 21, 2015

Amarantus BioScience reports data from LymPro Test

Jan. 19, 2015

Ultra-small nanoparticle probe for cancer diagnostics

Jan. 16, 2015

Enrollment open in phase II trial of OTL-38 imaging agent for ovarian cancer

Jan. 14, 2015

Biocept and Insight Genetics to advance NSCLC diagnostics

Jan. 13, 2015

Advanced Accelerator Applications acquires Atreus and starts phase I/II trial of imaging agent

Jan. 9, 2015

FDA approves Gadavist as contrast agent for pediatric patients under age 2

Jan. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.